Opioid induced esophageal dysfunction – Dan Patel

The approach to managing achalasia has been streamlined, but the management of non-achalasia motility disorders remains challenging. The ISDE (International Society for Diseases of the Esophagus) hosted a virtual presentation focused on the evaluation and management of non-achalasia motility disorders moderated by Michael Vaezi, Vanderbilt University Medical Center, USA.

During this 60-minute presentation, panelists discussed opioid-induced esophageal dysfunction, non-achalasia spastic disorders (jackhammer, distal esophageal spasm), and hypomotility disorders (ineffective esophageal motility and esophageal aperistalsis).

Learn more about other diseases of the esophagus topics at isde.net.

Join our community as a member isde.net/membership/

——————–

In this video Dan Patel breaks down opioid induced esophageal dysfunction referencing data from the US to help illustrate the importance of this issue. Two presentations were delivered during this virtual presentation and discussion, and questions were answered from a live audience.

Share with Colleagues:

You may also like

Medical and surgical management of non-achalasia motility - Arjan Bredenoord
20views
0likes
The approach to managing achalasia has been streamlined, but the management of non-achalasia motility disorders remains challenging. The ISDE (International Society for Diseases of the Esophagus) hosted a virtual presentation focused on the ...
Exploring Communication and Collaboration in our International, Multidisciplinary Esophageal Community – Walter Chan
ISDE Members Only
1views
0likes
Digital and social media play a crucial role in communication within the esophageal community, fostering collaboration among professionals and patients. With nearly 70% of the global population using social media, it serves as a vital tool for ...
Multidisciplinary Tumour Board Case Discussions: Case 2
ISDE Members Only
2views
0likes
Listen to the panel discussion on Case 2 of the Multidisciplinary Tumour Board, moderated by Andrew Barbour and Ken Kato. The international panel of experts included: Medical oncology – Kei Muro, Victoria Atkinson Radiation oncology – Karin ...
Robotic Esophagectomy Versus Minimally Invasive Esophagectomy – Suzanne Gisbertz
ISDE Members Only
1views
0likes
Listen to Dr. Suzanne Gisbertz present during the Robotic Esophageal Surgery Session held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this session, including: Robotic ...
Welcome & Context Setting: 2 Field vs 3 Field Lymphadenectomy - CS Pramesh
16views
0likes
This opening session from the International Society for Diseases of the Esophagus webinar provides a global overview of lymphadenectomy practices in esophageal cancer. Dr. C.S. Pramesh outlines key differences between 2-field and 3-field ...
2023 Presidential Plenary
ISDE Members Only
0views
0likes
The Presidential Plenary session features the following presentations: Can we optimize the recommendations for follow-up of Barrett’s Esophagus through critical analysis of risk factors in a specific population? – Sergio Szachnowicz The Tissue ...
Boerhaave’s Treatment in 2025; Is Organ Preserving Treatment Feasible – Mark van Berge Henegouwen
ISDE Members Only
1views
0likes
Listen to Dr. Mark van Berge Henegouwen present during the Leaks, Fistulas, Perforations Session held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this session, including: ...
Video Session: Esophageal Interventional Endoscopy and Surgical Innovations
ISDE Members Only
10views
0likes
This video session covers a range of topics including endoscopic techniques like flexible diverticulotomy and Z-Po, use of ICG to enhances visibility in surgeries, fluorescence technology, as well as robotic esophagectomy advancements and ...
When to consider surgery: Controversies in GERD Part 3 with John Lipham
22views
0likes
Gastroesophageal Reflux Disease (GERD) is the most prevalent esophageal disease. It is a condition affecting up to 20% of the western world and has a significant negative impact on the patient’s quality of life. The typical symptoms are ...
Page 1 of 14

Comments are closed.